A prospective multicenter randomized comparison between Holmium Laser Enucleation of the Prostate (HoLEP) and Thulium Laser Enucleation of the Prostate (ThuLEP).

Giorgio BozziniLorenzo BertiTahsin Batuhan AydoğanMatteo MaltagliatiJean Baptiste RochePierluigi BoveUmberto BesanaAlberto CaloriAntonio Luigi PastoreAlexander MüllerSalvatore MicaliMaria Chiara SighinolfiBernardo RoccoCarlo Buizza

Published in: World journal of urology (2020)

ThuLEP and HoLEP both relieved lower urinary tract symptoms equally, with high efficacy and safety. ThuLEP detemined reduced blood loss and early postoperative complications. Catheterization time, enucleated tissue, hospital stay, operative time and follow-up parameters did not show any significant difference.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
double blind
open label
placebo controlled
high speed
healthcare
prostate cancer
phase iii
clinical trial
cross sectional
acute care
emergency department
randomized controlled trial
high resolution
mass spectrometry
study protocol